The antipsychotic drug clozapine, acts via interaction with selective neurotransmitter receptor systems. Its use however, is associated with lifethreatening agranulocytosis. The mechanism by which this occurs and its possible relationship with the drug's atypicality remain unclear. As a first step in identifying mechanistic pathways involved, profiling of neurotransmitter receptors on human neutrophils, mononuclear and bone marrow stromal cells as putative targets for clozapine-mediated toxicity was undertaken. Expression of mRNA encoding dopaminergic d2, d3, d4; serotonergic 5ht2a, 5ht2c, 5ht3, 5ht6, 5ht7; adrenergic a1a, a2; histaminergic h1 and muscarinic m1, m2, m3, m4, m5 receptors was analyzed by reverse transcription-polymerase chain reaction methods. While 5ht2c, 5ht6, m1 and m2 mRNA were undetected, the presence of the other receptors indicates sites at which clozapine could bind and induce toxicity of neutrophils and stromal components which regulate granulopoiesis. The functional significance of differential receptor expression while unknown, may argue for neural regulation of hematopoiesis.
INTRODUCTION
Clozapine, an antipsychotic drug with superior efficacy in treating refractory schizophrenia, binds to dopaminergic D1-D5, serotonergic 5HT1A, 5HT2A, 5HT2C, 5HT3, 5HT6, 5HT7, adrenergic a1, muscarinic M1-M5 and histaminergic H1 and H3 neurotransmitter receptors. [1] [2] [3] Moreover, clozapine's side effects are partly predicted from its pharmacological profile. Therefore, sedation has been linked to antihistaminergic and noradrenergic actions, 4, 5 tachycardia and constipation related to anticholinergic properties 4, 6, 7 and weight gain correlated with antihistaminergic effects. 8 By contrast, clozapine's induction of a 0.9% incidence of agranulocytosis defined as a neutrophil count of o0.5 Â 10 9 /l, 9 cannot be predicted from the pharmacology of the drug and its etiology remains unclear. The onset of the disorder is usually marked by a gradual fall in white blood cell count extending over several weeks; rapid drops within 1 week may also occur, but are less common. 10 Most cases occur early in the course of treatment, within the first 18 weeks 9 with recovery within 14-24 days upon discontinuation of clozapine and accelerated on administration of granulocytemacrophage colony-stimulating factor or granulocyte colony-stimulating factor. 11 Since these clinical characteristics have provided a framework for study of the mature neutrophil, myeloid precursors or bone marrow stromal cells which regulate granulopoiesis 12 as putative target cells, the underlying cellular mechanisms of such interactions could be mediated through neurotransmitter receptors to which clozapine binds.
At therapeutic concentrations, clozapine binds covalently to activated human neutrophils both in vitro 13 and in vivo 14 with neutrophil apoptosis by a reactive nitrenium ion, linked to cell surface binding. 15 Covalent modification of neutrophil/bone marrow proteins by such reactive species could cause direct cell death, or alternatively, hapten formation and immune-mediated hypersensitivity. 12 Disruption to stromal cells may also arrest neutrophil development given their anatomical and functional link to hematopoietic precursor cells. 16 This assertion is consistent with marked bone marrow hypocellularity at the onset of clozapine-induced agranulocytosis with depletion of myeloid precursors and only occasional myeloblasts and promyelocytes, observed. 17 With regard to other drugs causing agranulocytosis, evidence supports metabolism within white blood cells as being causative for toxicity. 18 Whether toxicity in these instances occurs via interaction with cellular neurotransmitter receptor sites is unknown.
Neurotransmitters, however, may regulate hematopoiesis through synaptic connections between autonomic, noradrenergic and peptidergic nerve fibers and stromal/perivascular cells of the bone marrow 19 and are implicated in local inflammation, hypersensitivity reactions and leukocyte trafficking. 20 In addition, peripheral cells such as blood lymphocytes express D2, 21 29, 30 using radioligand binding studies. Since pharmacological characterization remains difficult given the lack of suitable receptor-specific ligands, 31 the expression of neurotransmitter receptors by the detection of corresponding mRNAs has recently been undertaken. 28, [32] [33] [34] If neurotransmitter receptors to which clozapine shows moderate to high affinity binding are found on peripheral white blood cells particularly the neutrophil and those of the bone marrow stroma, it remains possible that agranulocytosis may be related to pharmacological effects of the drug or its metabolites in susceptible individuals. In addition, the profiling of neurotransmitter receptors in these cells may enable the modulatory effect of clozapine to be examined. Hence, the expression of mRNA encoding dopaminergic, serotonergic, adrenergic, histaminergic and muscarinic receptors by human neutrophils, mononuclear leukocytes, and bone marrow stromal cells was analyzed by reverse transcription-polymerase chain reaction (RT-PCR) methods.
RESULTS
First-strand cDNA reactions for each cell type primed with either oligo(dT) [12] [13] [14] [15] [16] [17] [18] or random hexamers, essentially gave similar results with cDNA species of up to 8 kb synthesized (data not shown). Subsequent amplifications of cDNA prepared using either priming method gave identical results for each receptor targeted (Figure 1a-d) . In all cases, amplification of each receptor was confirmed using cDNA prepared from tissue known to express the receptors of interest. Single fragments of the expected length were obtained in each case using the designated primers ( Figure  1a-d) . Amplification of each receptor transcript in the cells targeted was then assessed as being detectable or undetectable relative to the positive control sample.
Receptor expression patterns were identical in all subjects with no sex differences found (Table 1 ). d2 and d4 mRNA were present in neutrophils, mononuclear and stromal cells, while d3 was only detectable in mononuclear cells. There was apparent absence of 5ht2c and 5ht6 in blood cells but presence of 5ht7 mRNA in all cells examined. Mononuclear leukocytes and stromal cells expressed mRNA for 5ht2a, while 5ht3 was only detected in mononuclear cells. 5ht2a and 5ht3 mRNA were absent in neutrophils. a2 mRNA was present in all cells, and a1a mRNA, while present in stromal cells was absent from peripheral white blood cells. h1 mRNA was not detected in neutrophils, but was found in mononuclear and stromal cells. While mRNA for m1 and m2 were not found, m3 and m4 receptors were detected in all cells. m5 mRNA was only detectable in mononuclear cells. Both neutrophils and bone marrow stromal cells were positive for elastase while, expectedly, mononuclear cells were not. All receptors identified in neutrophils were also found in both mononuclear and stromal cells. 
DISCUSSION
Analyses of the expression of dopaminergic, serotonergic, adrenergic, histaminergic and muscarinic receptors via detection of their corresponding mRNA in peripheral blood and bone marrow cells indicated differential patterns of expression. To date, such receptor expression profiles have not been reported in the human neutrophil or bone marrow stromal cell complement. While the former cells were a purified fraction of leukocytes, the latter comprised of a heterogeneous population of mesenchymal cells that grow as an adherent layer in long-term marrow cultures and have supportive functions for proliferation and differentiation of hematopoietic precursor cells. 35 Importantly, demonstration of clozapine-targeted neurotransmitter expression in these cells raises the possibility of their modulation by drug interaction.
Variability was noted in the mRNA expression levels of receptors between cell types and individual donors, although overall expression patterns were the same. Differences in expression levels may be the result of genetic determinants and/or regulated by environmental factors such as physiological stress and infection, 36 but such assessment was beyond the scope of this study.
While d2 and d4 mRNA were found in all cell types examined, d3 was of more limited distribution, detectable only in mononuclear cells. Previous studies have reported d3 and d4 mRNA expression in human peripheral blood lymphocytes, 31, 32, 37 but not d2 receptor mRNA 31 or immunoreactivity. 21 Methodological considerations, such as differences in primer design and cell purification, may account for the apparent discrepancy in the d2 finding. This study used primers, which were unable to differentiate between the d 2S (415) and d 2L (444) receptor isoforms, increasing the ability of transcript detection. In addition, d2 expression could be confined to the monocytic component of the mononuclear cell fraction examined.
These factors aside, the finding of different dopamine receptors in circulating leukocytes and cells of the marrow stroma, supports the contention of an involvement of dopamine in neuroimmune modulation such as the induction of neutrophil apoptosis for normal resolution of acute inflammatory response. 38 Of note also is the widespread distribution of d4 mRNA, a high affinity site for clozapine, 39 although no association between the polymorphic forms of d4 or variable clozapine response has been found. 40, 41 The mapping of serotonin receptors in peripheral blood cells indicated variable levels of expression, with 5ht7 mRNA most widely distributed and 5ht2c and 5ht6 mRNA undetected. Serotonin-mediated regulation of hematopoiesis via programmed cell death has been reported. 42 In addition, antagonism by serotonin of interferon g via 5HT2 receptors in the marrow macrophage has been demonstrated. 43 The present study found 5ht2a mRNA in stromal cells of the marrow which contain macrophages, 44 although cell-type-specific localization was not determined.
Adrenergic mRNA receptor expression, namely a1a on stromal cells and a2 on blood leukocytes and stromal cells, was also demonstrated in this study. The functional relevance of the wide pattern of distribution of a2 mRNA, Neurotransmitter receptors, blood cells and clozapine although unknown, is in possible accordance with adrenergic innervation into the bone marrow which terminates in association with stromal cells 19 and mediation of hematopoiesis via adrenoceptors. 45 While histamine receptors on hematopoietic progenitor cells 46 and antagonism by H1 receptor agonists of proliferation of colony-forming unit-granulocyte-macrophage 47 have been reported, the present study found an apparent lack of h1 mRNA expression in the mature neutrophil. There were however, detectable amounts of h1 mRNA in mononuclear and stromal cells, in keeping with the finding of immunoregulatory control of lymphocytes by histamine binding 48 and histamine release from mast cells. 49 Additionally, the recent discovery of the h4 receptor primarily expressed in bone marrow and eosinophils, but undetected in brain tempts speculation of a peripheral immune target particularly with respect to asthma and allergy, to which clozapine has moderate affinity. 50 The current data confirm and extend on previous pharmacological 26, 27 and mRNA expression studies that suggested the existence of multiple muscarinic receptors on blood lymphocytes. 33, 63, 51, 52 While mRNA for m3, m4, and m5 receptors has been reported in mononuclear cells, the additional detection of m3 and m4 mRNA in neutrophils and stromal cells remains a novel finding. Acetylcholine synthesis and release from T-lymphocytes via muscarinic receptors have been documented; 53 however, such stimulation of muscarinic receptors on stromal cells by direct contact through adhesion molecules remains to be defined. Whereas expression of mRNA for m1 and m2 receptors was not found in the cells examined, such expression has been demonstrated in mononuclear cells. 36, 52 The absence of receptor expression may reflect a true negative finding, or may result from low copy number transcripts that remain undetectable using the methods employed. However, given the sensitivity of RT-PCR analysis, one may question the functional relevance of seemingly absent, very low-density receptor sites. Muscarinic receptor expression patterns were identical in all subjects, which is in contrast to a previous study which found interindividual variability in m1, m2 and m3 receptors, but common expression of m4 and m5 by mononuclear cells from each donor. 36 In view of these findings, the possibility that expression of receptors depends on specific lineage and/or activation status of the cell cannot be excluded.
In relation to clozapine-induced agranulocytosis, which is associated with toxicity directed at the bone marrow or the peripheral blood neutrophil, the identification of potential cellular binding sites is of value. This approach may enable the binding properties of drugs such as olanzapine or quetiapine, related in chemical structure and pharmacological profile to clozapine and recently associated with agranulocytosis, 54, 55 and those that are not, to be compared to highlight possible differences in receptor expression. This study found no neurotransmitter receptor that was neutrophil specific. Instead, overlap in neurotransmitter expression between cells suggests that toxicity targeted at the neutrophil may involve an additional interacting cellspecific drug-modified factor or polypeptide in susceptible individuals. The observation that reactive clozapine metabolites are more toxic to neutrophils from patients with a history of agranulocytosis supports this contention. 56 Alternatively, given the important finding of neurotransmitter receptors on stromal cells of the marrow, it is plausible that clozapine or its reactive metabolites may modulate or impair cell functioning. Further investigation of these cells is warranted to establish causative links with clozapineinduced agranulocytosis.
MATERIALS AND METHODS
Blood Cell Separation 45 ml of venous blood from three male and three female healthy subjects was diluted 9:1 with 1 ml of acid citrate dextrose (213 mM citric acid, 93 mM trisodium citrate, 111 nM dextrose) in EDTA tubes. 25 ml aliquots of anticoagulated blood were then layered over 13 ml of FicollPaque (Pharmacia Biotech) density gradient and centrifuged at 1500 g, for 15 min at 181C. Following separation, the plasma layer was removed and the mononuclear cell fraction collected, diluted with ice-cold phosphate-buffered saline (PBS) and centrifuged at 1500 g, for 10 min at 41C. Residual erythrocytes were lysed using ice-cold isotonic ammonium chloride solution (155 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA, pH 7.4). Resuspended cells were then centrifuged at 1560 g, for 5 min at 41C and the resulting cell pellet washed twice with PBS. Purity of the mononuclear fraction was 498% as assessed by morphologic examination of Leishman-stained (BDH) cell preparations. The remaining granulocyte/erythrocyte fraction was diluted with 17 ml PBS and erythrocytes rosetted using 5 ml, 6% dextran T500 (Pharmacia Biotech) for 50 min at room temperature. The granulocyte/dextran fraction was then 
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Neutrophil Isolation CD15 + neutrophils were purified using immunomagnetic separation with Dynabeads M-450 (Dynal) according to the manufacturer's protocol. Prewashed 2 Â 10 8 CD15 + magnetic beads in ice-cold PBS were added to the granulocyte cell suspension, and the sample incubated for 20 min at 41C on a tilting, rotation device. The sample was then diluted in icecold PBS washing buffer and rosetted cells collected using the Dynal magnetic particle concentrator. Rosetted cells were then resuspended in washing buffer and the isolation/ washing steps repeated five times. This yielded neutrophil preparations of 99% purity.
Bone Marrow Stromal Layer Separation
Bone marrow specimens were obtained by needle aspiration from normal donors and were collected with informed consent in accordance with The Royal Melbourne Hospital and The Alfred Hospital approved guidelines. Bone marrow mononuclear cells were isolated by Ficoll-Paque density gradient centrifugation and were used to initiate long-term bone marrow cultures using modification of a previously described method. 57 Cells were cultured at a concentration of 1 Â 10 6 cells/ml in Iscove's modified Dulbecco's medium supplemented with 10% fetal calf serum, penicillin-streptomycin-amphotericin antibiotic/antimycotic mixture (Gibco BRL), 1mM hydrocortisone and 50 mM mercaptoethanol (Sigma) at 371C, in a 5% CO 2 humidified incubator, for 14 days. Nonadherent cells were removed and the adherent cell layer constituting the stroma was washed twice with PBS and detached with 0.25% trypsin (Gibco BRL). Cells were resuspended in PBS and pelleted by centrifugation at 170 g for 5 min at 41C.
RNA Extraction and First Strand cDNA Synthesis
Total RNA was extracted from neutrophil, mononuclear and stromal cell fractions by modification of the guanidine isothiocyanate-phenol method, 58 using Trizol reagent (Gibco BRL). The integrity of the RNA isolated was assessed 
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Neurotransmitter receptors, blood cells and clozapine A Pereira et al by 1% denaturing agarose gel electrophoresis. Total RNA (5 mg) was treated with RNase-free DNase I (Boehringer Mannheim) to remove residual genomic DNA. First-strand cDNA was then synthesized from purified total RNA using SuperScript II Preamplification System (Gibco BRL) primed with oligo(dT) [12] [13] [14] [15] [16] [17] [18] and random hexamers. To increase the sensitivity of PCR amplification of cDNA targets, the RNA template was removed by digestion with 2.0 U RNase H after completion of first-strand synthesis.
Amplification of Target cDNA Target cDNA was amplified using PCR with forward and reverse oligonucleotide primers designed using GenBank sequences of the coding region of the following receptors: d2, d3, d4, 5ht2a, 5ht2c, 5ht3, 5ht6, 5ht7, a1a, a2, h1, m1, m2, m3, m4 and m5 (Table 2 ). Primers were designed utilizing MacVector (Oxford Molecular Group PLC) sequence analysis software and where possible as close to the 3 0 end of the coding sequence and within exons flanking introns to eliminate the possibility of amplification of contaminating genomic DNA. The d2 primers were unable to differentiate between the d 2S (415) and d 2L (444) receptor isoforms, 59 while the d3, 5ht2c, 5ht3 and 5ht7 primers were designed in regions common to the full-length transcript and truncated variants. [60] [61] [62] [63] Primers and conditions used for amplification of the d4 receptor were as previously published. 32 In addition, primers were not designed within known polymorphic coding regions such as for the 5ht2a and 5ht6 receptors. 64, 65 Given the existence of multiple isoforms of the a1a receptor, 66 primers that were specific for this subtype but did not pertain to a particular isoform were used.
Amplification of cDNA for each receptor was undertaken using cDNA of human brain cortex, caudate nucleus or white blood cells as a positive control. Amplification without template was included in all experiments as a negative control. cDNA of elastase, a neutrophilspecific protein, was amplified to demonstrate specificity of cell separation. PCR was performed in a final volume of 50 ml, containing 2 ml of cDNA, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 or 2.0 mM MgCl 2 , 0.25 mM dNTPs, 2.0 mM of each primer and 2.5 U of Taq DNA polymerase (Gibco BRL). PCR cycling parameters for each receptor were as outlined in Table 3 . PCR products were analyzed by 2% agarose gel electrophoresis (1 : 1 NuSieve 3 : 1 agarose (FMC BioProducts) : agarose (International Biotechnologies Inc.) in the presence of 0.5 mg/ml ethidium bromide. Fragment sizes were estimated using 50 and 
